John Simard News Today

Margaret (Simard) Mulligan passed away. This is the full obituary where you can share condolences and memories. Published in the Salem News on 2024-04-22.

Key Insights XBiotech's significant retail investors ownership suggests that the key decisions are influenced by...

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

AUSTIN, Texas, Jan. 04, 2024 -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility....

Key Insights The considerable ownership by individual investors in XBiotech indicates that they collectively have a...

StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a report published on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance NASDAQ XBIT opened at $5.28 on Friday. XBiotech has a 12 month low of $3.00 and a 12 month high of $6.49. The firm […]

StockNews.com started coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a report released on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. XBiotech Price Performance Shares of XBIT opened at $5.11 on Friday. XBiotech has a 1-year low of $3.00 and a 1-year high of $6.49. The company has […]

XBiotech Inc. (NASDAQ:XBIT – Get Rating) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 83,800 shares, a growth of 23.1% from the April 30th total of 68,100 shares. Approximately 0.5% of the shares of the stock are sold short. Based on an […]

StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research report released on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. XBiotech Stock Up 1.5 % Shares of XBIT opened at $5.47 on Thursday. The company’s fifty day moving average is $3.70 and its 200-day moving […]

StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research report released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBiotech stock opened at $5.47 on Thursday. XBiotech has a 12 month low of $3.00 and a 12 month high of $6.49. The […]